Get the app!
Back to Trades

Kennedy Patrick

DirectorCIK 0002013944

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025–2026

Kennedy Patrick, Director, has filed 2 SEC reports (2025–2026), all concentrated in Jazz Pharmaceuticals plc (JAZZ), totaling $217.9K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Aug 7JAZZ
Jazz Pharmaceuticals plc
Kennedy PatrickDirectorGrant$0
Aug 11JAZZ
Jazz Pharmaceuticals plc
Kennedy PatrickDirectorGrant$217.9K

2 filings